Breast Fat Grafting
Also known as: autologous fat breast augmentation, fat transfer breast augmentation
Breast fat grafting (fat transfer breast augmentation) uses the patient's own liposuctioned fat to modestly enlarge or reshape the breast without an implant.
가슴 지방이식 후 브라 착용은 언제부터, 어떤 종류가 좋은가요? 압박하면 생착에 방해가 되나요?
가슴 지방이식 뒤에는 가슴을 조이는 속옷이 아니라 받쳐 주되 누르지 않는 브라가 권고됩니다. 이식한 지방은 주변 조직과 혈관이 다시 이어져야 살아남기 때문에, 문헌들은 가슴에 가해지는 압박과 쓸림을 줄이라고 설명하고, 한 종설은 이식 부위 압박복을 수술 후 4주간 피하라고 안내합니다. 반대로 지방을 뺀 부위에는 압박복을 입습니다. 다만 이는 전문가 권고 수준이며, 압박 정도와 생착률을 사람에게서 직접 비교한 임상시험은 확인되지 않았습니다. 착용 시작 시점과 종류는 집도의 지시가 우선입니다.
Key facts
| Predicate | Value | Source |
|---|---|---|
| Definition | Fat is taken by liposuction from other parts of the body and injected to enlarge the breasts | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Typical donor sites | Usually the abdomen or flanks, though fat can be taken from almost anywhere (surgeon quoted by ASPS)as of Nov 18, 2024 | [3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons |
| Typical size increase | Surgeon quoted by ASPS: ideal candidate wants half a cup to one cup; a larger increase may take two to three procedures cup sizeas of Nov 18, 2024 | [3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons |
| Listed risks | Cysts, infection, microcalcification, death of fat cells (necrosis), and some transferred fat leaving the breast area | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Pre-expansion option | Surgeons may recommend an external tissue expansion system in the weeks before surgery | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Pooled volume retention | 54% (95% CI 48.5–59.5%) across 25 studies, follow-up 3–36 months percentas of Feb 1, 2024 | [4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) |
| Retention by fat preparation method | Centrifugation 51.5% vs sedimentation 38.7% pooled retention percentas of Feb 1, 2024 | [4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) |
| Oncologic safety evidence | Meta-analysis of 15 studies (8,541 participants): no difference in overall survival, disease-free survival or local recurrence between patients who had fat grafting after breast cancer surgery and controlsas of Apr 1, 2022 | [5]journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract recordBMC Cancer (via Europe PMC) |
| 1987 professional position | ASPRS (predecessor of ASPS) condemned autologous fat injection for breast augmentation over concerns about cancer detection | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| 2009 ASPS Fat Graft Task Force | Concluded that the literature then available showed no association between fat grafting and higher rates of malignancy | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| US regulatory status | Following FDA guidance issued in November 2017, autologous fat grafts do not require premarket approval; stromal vascular fraction products receive closer reviewas of Nov 1, 2017 | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| Relevant FDA guidance | Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exceptionas of Nov 1, 2017 | [7]governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionUS Food and Drug Administration (CBER) |
| Suitable for | People wanting a relatively small increase in breast size who have enough donor fat (ASPS) | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
| Sessions | More than one session may be needed because part of the graft is resorbed | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
| Imaging note | Fat necrosis, cysts and calcifications can appear on mammograms and must be interpreted by a radiologist | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
Overview
Breast fat grafting (fat transfer breast augmentation) is a surgical procedure that uses liposuction to take a patient's own fat, usually from the abdomen or flanks, and inject it into the breasts after processing. It is used for small cosmetic augmentations and alongside breast reconstruction. Only part of the injected fat survives. A 2024 meta-analysis of 25 studies found that about 54% of the grafted volume remained, with results varying by how the fat was prepared. Reported risks include fat necrosis, cysts, microcalcifications and infection. A meta-analysis of breast cancer patients found no difference in survival or local recurrence between those who had fat grafting and those who did not. In the US, fat removed and reinjected in the same operation can qualify for an FDA same-surgical-procedure exception. Readers should check the surgeon's training, how much volume to expect and what breast imaging follow-up is planned.
Verified providers
Sponsored listings are labeled. Verification is independent of payment.SC301의원
SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.
View providerEvidence & claims
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise.| Claim | Type | Evidence | Source |
|---|---|---|---|
| Fat transfer breast augmentation produces a relatively small size increase and may need repeat sessions. | outcome | limited | Fat Transfer Breast Augmentation |
References
Independent source ratio 85% (23/27) · Provider-authored 2- Level C · organizationFat Transfer Breast Augmentation — American Society of Plastic Surgeons · accessed Nov 12, 2026 · Evidence page
- Level C · organizationFat Transfer Breast Augmentation Risks and Safety — American Society of Plastic Surgeons · accessed Nov 11, 2026 · Evidence page
- Level C · organizationFat transfer for breast augmentation: The ins and outs of this implant alternative — American Society of Plastic Surgeons · accessed Nov 11, 2026 · Evidence page
- Level B · journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract record — Journal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) · accessed Oct 29, 2026 · Evidence page
- Level B · journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract record — BMC Cancer (via Europe PMC) · accessed Oct 29, 2026 · Evidence page
- Level B · journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64) — Seminars in Plastic Surgery (Thieme) via PubMed Central · accessed Nov 11, 2026 · Evidence page
- Level A · governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception — US Food and Drug Administration (CBER) · accessed Nov 12, 2026 · Evidence page
- Level A · governmentBreast enlargement (implants) — NHS (UK National Health Service) · accessed Nov 12, 2026 · Evidence page
- Level C · organizationBreast Augmentation — American Society of Plastic Surgeons · accessed Nov 12, 2026 · Evidence page
- Level B · academicAdvancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies — Frontiers in Cell and Developmental Biology (2026) · accessed Nov 12, 2026 · Evidence page
- Level B · academicProvider-authoredA Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384) — Annals of Plastic Surgery · accessed Nov 12, 2026 · Evidence page
- Level B · academicImpact of donor site on fat graft survival in autologous fat transfer to the breast: A systematic review — JPRAS Open (2026) · accessed Nov 12, 2026 · Evidence page
- Level B · academicCell-Assisted Lipotransfer: A Systematic Review of its Efficacy — Aesthetic Plastic Surgery (2024) · accessed Nov 12, 2026 · Evidence page
- Level B · academicComparison of the Efficacy and Safety of Cell-Assisted Lipotransfer and Platelet-Rich Plasma Assisted Lipotransfer — Cell Transplantation (2021) · accessed Nov 12, 2026 · Evidence page
- Level B · academicSafety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review — Stem Cell Research & Therapy (2026) · accessed Nov 12, 2026 · Evidence page
- Level B · academicProvider-authoredBreast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020) — Aesthetic Surgery Journal Open Forum · accessed Nov 12, 2026 · Evidence page
- Level A · governmentFDA Warns About Stem Cell Therapies — U.S. Food and Drug Administration · accessed Sep 15, 2026 · Evidence page
- Level C · organization지방이식 (Fat transplantation) — N의학정보 — 서울대학교병원 · accessed Nov 12, 2026 · Evidence page
- Level A · governmentLiposuction — NHS (UK National Health Service) · accessed Nov 12, 2026 · Evidence page
- Level A · governmentSurgical fat transfer (lipofilling) — NHS (UK National Health Service) · accessed Nov 12, 2026 · Evidence page
- organization乳房への脂肪移植術の治療手順(第2版・2025年6月作成) — 日本乳房オンコプラスティックサージャリー学会 脂肪移植WG · accessed Nov 12, 2026 · Evidence page
- Level B · academicDegeneration, regeneration, and cicatrization after fat grafting: dynamic total tissue remodeling during the first 3 months (Kato H, … Yoshimura K; Plast Reconstr Surg 2014) — Plastic and Reconstructive Surgery · accessed Nov 12, 2026 · Evidence page
- Level A · government確認してください!美容医療の施術を受ける前にもう一度! — 厚生労働省 · accessed Nov 12, 2026 · Evidence page
- government美容医療サービス(各種相談の件数や傾向) — 独立行政法人 国民生活センター · accessed Nov 12, 2026 · Evidence page
- Level B · academicLong-Term Volume Retention of Breast Augmentation with Fat Grafting Depends on Weight Changes: A 3-Year Prospective Magnetic Resonance Imaging Study (Ørholt M, … ; Plast Reconstr Surg 2025;155(6):947-954) — Plastic and Reconstructive Surgery · accessed Nov 10, 2026 · Evidence page
- Level B · academicFat survival following autologous fat transfer to the native breast: A systematic review and meta-analysis (Giannas E, … ; J Plast Reconstr Aesthet Surg 2026;115:146-156) — Journal of Plastic, Reconstructive & Aesthetic Surgery · accessed Nov 10, 2026 · Evidence page
- Level B · academicBreast fat grafting and cancer: a systematic review of the science behind enhancements and concerns (Valente DS, … ; Transl Breast Cancer Res 2024;5:14) — Translational Breast Cancer Research · accessed Nov 10, 2026 · Evidence page